{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:54:04Z","timestamp":1763564044888,"version":"3.45.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004593","name":"Universidad Aut\u00f3noma de Madrid","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Evolutionary approach tries to explain several aspects of neurological diseases under the perspective of evolution. Evolutive bottle-neck may explain some aspects of neurodegenerative diseases. Additionally, a number of genetic alleles may reflect an evolutionary trade-off between benefits in early life and late-life disadvantages. Antagonistic pleiotropy theory suggests that some adaptive evolutionary changes increase individual fitness early in life, but can exacerbate detrimental aging-related processes We discuss three diseases with movement disorders from an evolutionary perspective: Parkinson\u2019s disease, Huntington\u2019s disease, and Tourette syndrome.<\/jats:p>","DOI":"10.1007\/s00702-025-03025-8","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:23:56Z","timestamp":1760541836000},"page":"1629-1633","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Movement disorders: a brief overview from an evolutionary perspective"],"prefix":"10.1007","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6194-672X","authenticated-orcid":false,"given":"Pedro J.","family":"Garcia Ruiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"3025_CR1","doi-asserted-by":"publisher","first-page":"105609","DOI":"10.1016\/j.neubiorev.2024.105609","volume":"159","author":"JF Baizabal-Carvallo","year":"2024","unstructured":"Baizabal-Carvallo JF, Cavanna AE, Jankovic J (2024) Tics emergencies and malignant tourette syndrome: assessment and management. Neurosci Biobehav Rev 159:105609. https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105609","journal-title":"Neurosci Biobehav Rev"},{"key":"3025_CR2","doi-asserted-by":"publisher","unstructured":"Barron JC, Hurley EP, Parsons MP (2021) Huntingtin and the synapse. Front Cell Neuroscience 15:689332. https:\/\/doi.org\/10.3389\/fncel.2021.689332","DOI":"10.3389\/fncel.2021.689332"},{"issue":"10291","key":"3025_CR3","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"key":"3025_CR4","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/mds.25135","volume":"27","author":"JP Bolam","year":"2012","unstructured":"Bolam JP, Pissadaki EK (2012) Living on the edge with too many mouths to feed: why dopamine neurons die. Mov Disord 27:1478\u20131483. https:\/\/doi.org\/10.1002\/mds.25135","journal-title":"Mov Disord"},{"issue":"4","key":"3025_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/mds.27628","volume":"34","author":"NJ Diederich","year":"2019","unstructured":"Diederich NJ, James Surmeier D, Uchihara T, Grillner S, Goetz CG (2019) Parkinson\u2019s disease: is it a consequence of human brain evolution? Mov Disord 34(4):453\u2013459. https:\/\/doi.org\/10.1002\/mds.27628","journal-title":"Mov Disord"},{"issue":"7","key":"3025_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.tins.2020.05.001","volume":"43","author":"NJ Diederich","year":"2020","unstructured":"Diederich NJ, Uchihara T, Grillner S, Goetz CG (2020) The Evolution-Driven signature of parkinson\u2019s disease. Trends Neurosci 43(7):475\u2013492. https:\/\/doi.org\/10.1016\/j.tins.2020.05.001","journal-title":"Trends Neurosci"},{"issue":"7","key":"3025_CR7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.tins.2008.03.006","volume":"31","author":"JW Fondon 3rd","year":"2008","unstructured":"Fondon JW 3rd, Hammock EA, Hannan AJ, King DG (2008) Simple sequence repeats: genetic modulators of brain function and behavior. Trends Neurosci 31(7):328\u2013334. https:\/\/doi.org\/10.1016\/j.tins.2008.03.006","journal-title":"Trends Neurosci"},{"issue":"4","key":"3025_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s004150200035","volume":"249","author":"PJ Garc\u00eda Ruiz","year":"2002","unstructured":"Garc\u00eda Ruiz PJ, Hern\u00e1ndez J, Cantarero S, Bartolom\u00e9 M, S\u00e1nchez Bernardos V, Garc\u00eda de Y\u00e9benes J (2002) Bradykinesia in huntington\u2019s disease. A prospective, follow-up study. J Neurol 249(4):437\u2013440. https:\/\/doi.org\/10.1007\/s004150200035","journal-title":"J Neurol"},{"key":"3025_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fneur.2017.00157","volume":"1","author":"PJ Garcia-Ruiz","year":"2017","unstructured":"Garcia-Ruiz PJ, Espay AJ (2017) Parkinson disease: an evolutionary perspective. Front Neurol 1:8:157. https:\/\/doi.org\/10.3389\/fneur.2017.00157","journal-title":"Front Neurol"},{"issue":"9","key":"3025_CR10","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.4049\/jimmunol.1000548","volume":"185","author":"A Gardet","year":"2010","unstructured":"Gardet A, Benita Y, Li C, Sands BE, Ballester I, Stevens C, Korzenik J et al (2010) LRRK2 is involved in the IFN-\u03b3 response and host response to pathogens. J Immunol 185(9):5577\u20135585. https:\/\/doi.org\/10.4049\/jimmunol.1000548","journal-title":"J Immunol"},{"key":"3025_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/B978-0-444-63233-3.00017-8","volume":"147","author":"R Ghosh","year":"2018","unstructured":"Ghosh R, Tabrizi SJ (2018) Huntington disease. Handb Clin Neurol 147:255\u2013278. https:\/\/doi.org\/10.1016\/B978-0-444-63233-3.00017-8","journal-title":"Handb Clin Neurol"},{"issue":"11","key":"3025_CR12","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1001\/archneur.1993.00540110037003","volume":"50","author":"JF Gusella","year":"1993","unstructured":"Gusella JF, MacDonald ME, Ambrose CM, Duyao MP (1993) Molecular genetics of huntington\u2019s disease. Arch Neurol 50(11):1157\u20131163. https:\/\/doi.org\/10.1001\/archneur.1993.00540110037003","journal-title":"Arch Neurol"},{"issue":"3","key":"3025_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3233\/JPD-181365","volume":"8","author":"M Hashimoto","year":"2018","unstructured":"Hashimoto M, Ho G, Takamatsu Y, Shimizu Y, Sugama S, Takenouchi T, Waragai M, Masliah E (2018) Evolvability and neurodegenerative disease: antagonistic Pleiotropy phenomena derived from amyloid aggregates. J Parkinsons Dis 8(3):405\u2013408. https:\/\/doi.org\/10.3233\/JPD-181365","journal-title":"J Parkinsons Dis"},{"issue":"7","key":"3025_CR14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cub.2011.02.047","volume":"21","author":"SR Jackson","year":"2011","unstructured":"Jackson SR, Parkinson A, Jung J, Ryan SE, Morgan PS, Hollis C, Jackson GM (2011) Compensatory neural reorganization in tourette syndrome. Curr Biol 21(7):580\u2013585. https:\/\/doi.org\/10.1016\/j.cub.2011.02.047","journal-title":"Curr Biol"},{"issue":"2","key":"3025_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1474-4422(22)00303-9","volume":"22","author":"KA Johnson","year":"2023","unstructured":"Johnson KA, Worbe Y, Foote KD, Butson CR, Gunduz A, Okun MS (2023) Tourette syndrome: clinical features, pathophysiology, and treatment. Lancet Neurol 22(2):147\u2013158. https:\/\/doi.org\/10.1016\/S1474-4422(22)00303-9","journal-title":"Lancet Neurol"},{"key":"3025_CR16","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"29","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 29:386 896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet"},{"key":"3025_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ebiom.2018.03.031","volume":"31","author":"JK Lee","year":"2018","unstructured":"Lee JK, Conrad A, Epping E, Mathews K, Magnotta V, Dawson JD, Nopoulos P (2018) Effect of trinucleotide repeats in the huntington\u2019s gene on intelligence. EBioMedicine 31:47\u201353. https:\/\/doi.org\/10.1016\/j.ebiom.2018.03.031","journal-title":"EBioMedicine"},{"key":"3025_CR18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1523\/JNEUROSCI.4029-08.2009","volume":"29","author":"W Matsuda","year":"2009","unstructured":"Matsuda W, Furuta T, Nakamura KC, Hioki H, Fujiyama F, Arai R, Kaneko T (2009) Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci 29:444\u2013453. https:\/\/doi.org\/10.1523\/JNEUROSCI.4029-08.2009","journal-title":"J Neurosci"},{"issue":"1","key":"3025_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25(1):24\u201334. https:\/\/doi.org\/10.1111\/ene.13413","journal-title":"Eur J Neurol"},{"issue":"1","key":"3025_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41598-018-37102-8","volume":"9","author":"AJ Morton","year":"2019","unstructured":"Morton AJ, Skillings EA, Wood NI, Zheng Z (2019) Antagonistic Pleiotropy in mice carrying a CAG repeat expansion in the range causing huntington\u2019s disease. Sci Rep 9(1):37. https:\/\/doi.org\/10.1038\/s41598-018-37102-8","journal-title":"Sci Rep"},{"issue":"5","key":"3025_CR21","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/ana.27046","volume":"96","author":"M Neema","year":"2024","unstructured":"Neema M, Schultz JL, Langbehn DR, Conrad AL, Epping EA, Magnotta VA, Nopoulos PC (2024) Mutant Huntingtin drives development of an advantageous brain early in life: evidence in support of antagonistic Pleiotropy. Ann Neurol 96(5):1006\u20131019. https:\/\/doi.org\/10.1002\/ana.27046","journal-title":"Ann Neurol"},{"issue":"5","key":"3025_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/scientificamerican","volume":"279","author":"RM Nesse","year":"1998","unstructured":"Nesse RM, Williams GC (1998) Evolution and the origins of disease. Sci Am 279(5):86\u201393. https:\/\/doi.org\/10.1038\/scientificamerican","journal-title":"Sci Am"},{"key":"3025_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fncom.2013.00013","volume":"7","author":"EK Pissadaki","year":"2013","unstructured":"Pissadaki EK, Bolam JP (2013) The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in parkinson\u2019s disease. Front Comput Neurosci 7:13. 10.3389","journal-title":"Front Comput Neurosci"},{"key":"3025_CR24","doi-asserted-by":"publisher","first-page":"107123","DOI":"10.1016\/j.parkreldis.2024.107123","volume":"129","author":"K Poplawska-Domaszewicz","year":"2024","unstructured":"Poplawska-Domaszewicz K, Qamar MA, Falup Pecurariu C, Chaudhuri KR (2024) Recognition and characterising non-motor profile in early onset parkinson\u2019s disease (EOPD). Parkinsonism Relat Disord 129:107123. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.107123","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"3025_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.tins.2021.06.006","volume":"44","author":"F Provenzano","year":"2021","unstructured":"Provenzano F, Deleidi M (2021) Reassessing neurodegenerative disease: immune protection pathways and antagonistic Pleiotropy. Trends Neurosci 44(10):771\u2013780. https:\/\/doi.org\/10.1016\/j.tins.2021.06.006","journal-title":"Trends Neurosci"},{"key":"3025_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mehy.2016.12.005","volume":"99","author":"JE Reser","year":"2017","unstructured":"Reser JE (2017) Tourette syndrome in the context of evolution and behavioral ecology. Med Hypotheses 99:35\u201339. https:\/\/doi.org\/10.1016\/j.mehy.2016.12.005","journal-title":"Med Hypotheses"},{"key":"3025_CR27","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00702-019-02025-9","volume":"126","author":"P Riederer","year":"2019","unstructured":"Riederer P, Berg D, Casadei N, Cheng F, Classen J, Dresel C, Jost W et al (2019) \u03b1-Synuclein in parkinson\u2019s disease: causal or bystander? J Neural Transm (Vienna) 126:815\u2013840. https:\/\/doi.org\/10.1007\/s00702-019-02025-9","journal-title":"J Neural Transm (Vienna)"},{"key":"3025_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00702-023-02630-9","volume":"130","author":"P Riederer","year":"2023","unstructured":"Riederer P, Nagatsu T, Youdim MBH, Wulf M, Dijkstra JM, Sian Huelsmann J (2023) Lewy bodies, iron, inflammation, and neuromelanin: pathological aspects underlying parkinson\u2019s disease. J Neural Transm (Vienna) 130:627\u2013646. https:\/\/doi.org\/10.1007\/s00702-023-02630-9","journal-title":"J Neural Transm (Vienna)"},{"key":"3025_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/bs.pbr.2022.10.004","volume":"275","author":"BA Rigby Dames","year":"2023","unstructured":"Rigby Dames BA, Kilili H, Charvet CJ, D\u00edaz-Barba K, Proulx MJ, de Sousa AA, Urrutia AO (2023) Evolutionary and genomic perspectives of brain aging and neurodegenerative diseases. Prog Brain Res 275:165\u2013215. https:\/\/doi.org\/10.1016\/bs.pbr.2022.10.004","journal-title":"Prog Brain Res"},{"issue":"6868","key":"3025_CR32","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1136\/bmj.305.6868.1515","volume":"305","author":"O Sacks","year":"1992","unstructured":"Sacks O (1992) Tourette\u2019s syndrome and creativity. BMJ 305(6868):1515\u20131516. https:\/\/doi.org\/10.1136\/bmj.305.6868.1515","journal-title":"BMJ"},{"key":"3025_CR33","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1001\/jamaneurol.2016.0947","volume":"73","author":"R Savica","year":"2016","unstructured":"Savica R, Grossardt B, Bower J, Ahlskog E, Rocca W (2016) Time trends in the incidence of Parkinson disease. JAMA Neurol 73:981\u2013989. https:\/\/doi.org\/10.1001\/jamaneurol.2016.0947","journal-title":"JAMA Neurol"},{"issue":"3","key":"3025_CR30","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3233\/JAD-221218","volume":"93","author":"CJ Smith","year":"2023","unstructured":"Smith CJ, Ashford JW (2023) Apolipoprotein e4-Associated protection against pediatric enteric infections is a survival advantage in Pre-Industrial populations. J Alzheimers Dis 93(3):907\u2013918. https:\/\/doi.org\/10.3233\/JAD-221218","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"3025_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM (2017) Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci 18(2):101\u2013113. https:\/\/doi.org\/10.1038\/nrn.2016.178","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"3025_CR31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12872-024-03808-z","volume":"24","author":"CC Topriceanu","year":"2024","unstructured":"Topriceanu CC, Shah M, Webber M, Chan F, Shiwani H, Richards M, Schott J et al (2024) APOE \u03b54 carriage associates with improved myocardial performance from adolescence to older age. BMC Cardiovasc Disord 24(1):172. https:\/\/doi.org\/10.1186\/s12872-024-03808-z","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"3025_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3233\/JHD-200394","volume":"9","author":"E van der Plas","year":"2020","unstructured":"van der Plas E, Schultz JL, Nopoulos PC (2020) The neurodevelopmental hypothesis of huntington\u2019s disease. J Huntingtons Dis 9(3):217\u2013229. https:\/\/doi.org\/10.3233\/JHD-200394","journal-title":"J Huntingtons Dis"},{"issue":"3","key":"3025_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/mds.10718","volume":"19","author":"JP van Vugt","year":"2004","unstructured":"van Vugt JP, Piet KK, Vink LJ, Siesling S, Zwinderman AH, Middelkoop HA, Roos RA (2004) Objective assessment of motor slowness in huntington\u2019s disease: clinical correlates and 2-year follow-up. Mov Disord 19(3):285\u2013297. https:\/\/doi.org\/10.1002\/mds.10718","journal-title":"Mov Disord"},{"issue":"6","key":"3025_CR37","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1042\/BST20180463","volume":"47","author":"RL Wallings","year":"2019","unstructured":"Wallings RL, Tansey MG (2019) LRRK2 regulation of immune-pathways and inflammatory disease. Biochem Soc Trans 47(6):1581\u20131595. https:\/\/doi.org\/10.1042\/BST20180463","journal-title":"Biochem Soc Trans"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03025-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-025-03025-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-025-03025-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:44:20Z","timestamp":1763563460000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-025-03025-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["3025"],"URL":"https:\/\/doi.org\/10.1007\/s00702-025-03025-8","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"type":"print","value":"0300-9564"},{"type":"electronic","value":"1435-1463"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Garcia Ruiz has received research support from Allergan; personal compensation as a consultant\/scientific advisory board member from Italfarmaco, Britannia, Bial, Esteve, Merz, and Stada; and speaking honoraria from Italfarmaco, Bial, Esteve and Abbvie.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study does not be required traditional ethical.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study does not be required consent to participate due to its nature of being a review article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study does not require consent to publish; it is a review article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}